• Stratec raised its 2026 adjusted EBIT margin forecast to 13%-15% from around 10%, excluding the loss-making Diatron business being sold.
• Constant-currency sales are expected to remain stable or rise slightly against pro forma 2025 sales of €223.5 million.
• The €10 million Diatron sale is expected to close in the fourth quarter; the business faces an annual adjusted EBIT loss around €10 million.
• Transaction-related noncash charges comprise €44.1 million in third-quarter impairments and an expected fourth-quarter deconsolidation loss of €4 million-€9 million.
• Medium-term targets were withdrawn, with updated targets due no later than publication of the 2026 annual report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stratec SE published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2425848_en) on October 30, 2026, and is solely responsible for the information contained therein.